Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia

Derrick Lopez, Francesco Sanfilippo, Benjamin Daniels, Sallie Pearson, Angelita Martini, David Preen

Research output: Contribution to conferenceConference presentation/ephemera

Abstract

Aims: The field of pharmacoepidemiology research has grown significantly in recent decades in Australia and internationally. Despite recent investments in infrastructure and the development of policy frameworks to support research using routinely-collected data, there has been little matching investment in expanding Australia’s human capacity to do this research. Available literature suggests a need to broaden the skills base of the existing research workforce and to form larger, interdisciplinary teams incorporating capabilities ranging from computer science, research translation to research management. However, these needs are not based on empirical evidence or prioritised based on stakeholder needs. Therefore, research is needed to understand the state of the current Australian pharmacoepidemiology workforce and to prioritise its capacity building needs. This is important now in light of Australia’s growing infrastructure of routinely-collected datasets, including Pharmaceutical Benefits Scheme data. Therefore, we aim to: (1) enumerate the number of pharmacoepidemiology researchers available and estimate the number required in the Australian setting; (2) profile the current pharmacoepidemiology research workforce (e.g. skills, qualifications); and (3) explore views and perspectives of senior stakeholders and researchers on issues relevant to building capacity in the pharmacoepidemiology research workforce and research environment within the country. This paper presents our proposed study and research approach to a key target audience.

Methods: Interviews with senior stakeholders (face-to-face or Skype) and surveys of pharmacoepidemiology researchers (using SurveyMonkey) will be undertaken in Australia to identify issues pertinent to building capacity in the pharmacoepidemiology research workforce. Mixed-methods approach will be used to analyse responses.

Results and conclusion: This project addresses one of the aims of a major Australian Centre of Research Excellence: to build national workforce capacity and processes in pharmacoepidemiology research and policy translation. Findings from this study will allow the development of a National program to build workforce capacity in pharmacoepidemiology research.
Original languageEnglish
Number of pages1
Publication statusPublished - Oct 2017
EventAsian Conference on Pharmacoepidemiology - The Pharmacy Australia Centre of Excellence (PACE), School of Pharmacy, The University of Queensland 20 Cornwall St, Woolloongabba QLD 4102, Brisbane, Australia
Duration: 29 Oct 201731 Oct 2017
Conference number: 10
https://acpe2017.org/

Conference

ConferenceAsian Conference on Pharmacoepidemiology
Abbreviated titleACPE
CountryAustralia
CityBrisbane
Period29/10/1731/10/17
Internet address

Fingerprint

stakeholder
infrastructure
research approach
computer science
pharmaceutical
qualification
interview
management
evidence
literature

Cite this

Lopez, D., Sanfilippo, F., Daniels, B., Pearson, S., Martini, A., & Preen, D. (2017). Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia. Paper presented at Asian Conference on Pharmacoepidemiology, Brisbane, Australia.
Lopez, Derrick ; Sanfilippo, Francesco ; Daniels, Benjamin ; Pearson, Sallie ; Martini, Angelita ; Preen, David. / Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia. Paper presented at Asian Conference on Pharmacoepidemiology, Brisbane, Australia.1 p.
@conference{4e37611267494efb809a1dce1367f4ce,
title = "Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia",
abstract = "Aims: The field of pharmacoepidemiology research has grown significantly in recent decades in Australia and internationally. Despite recent investments in infrastructure and the development of policy frameworks to support research using routinely-collected data, there has been little matching investment in expanding Australia’s human capacity to do this research. Available literature suggests a need to broaden the skills base of the existing research workforce and to form larger, interdisciplinary teams incorporating capabilities ranging from computer science, research translation to research management. However, these needs are not based on empirical evidence or prioritised based on stakeholder needs. Therefore, research is needed to understand the state of the current Australian pharmacoepidemiology workforce and to prioritise its capacity building needs. This is important now in light of Australia’s growing infrastructure of routinely-collected datasets, including Pharmaceutical Benefits Scheme data. Therefore, we aim to: (1) enumerate the number of pharmacoepidemiology researchers available and estimate the number required in the Australian setting; (2) profile the current pharmacoepidemiology research workforce (e.g. skills, qualifications); and (3) explore views and perspectives of senior stakeholders and researchers on issues relevant to building capacity in the pharmacoepidemiology research workforce and research environment within the country. This paper presents our proposed study and research approach to a key target audience.Methods: Interviews with senior stakeholders (face-to-face or Skype) and surveys of pharmacoepidemiology researchers (using SurveyMonkey) will be undertaken in Australia to identify issues pertinent to building capacity in the pharmacoepidemiology research workforce. Mixed-methods approach will be used to analyse responses.Results and conclusion: This project addresses one of the aims of a major Australian Centre of Research Excellence: to build national workforce capacity and processes in pharmacoepidemiology research and policy translation. Findings from this study will allow the development of a National program to build workforce capacity in pharmacoepidemiology research.",
keywords = "Workforce, pharmacoepidemiology",
author = "Derrick Lopez and Francesco Sanfilippo and Benjamin Daniels and Sallie Pearson and Angelita Martini and David Preen",
year = "2017",
month = "10",
language = "English",
note = "Asian Conference on Pharmacoepidemiology, ACPE ; Conference date: 29-10-2017 Through 31-10-2017",
url = "https://acpe2017.org/",

}

Lopez, D, Sanfilippo, F, Daniels, B, Pearson, S, Martini, A & Preen, D 2017, 'Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia' Paper presented at Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29/10/17 - 31/10/17, .

Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia. / Lopez, Derrick; Sanfilippo, Francesco; Daniels, Benjamin; Pearson, Sallie; Martini, Angelita; Preen, David.

2017. Paper presented at Asian Conference on Pharmacoepidemiology, Brisbane, Australia.

Research output: Contribution to conferenceConference presentation/ephemera

TY - CONF

T1 - Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia

AU - Lopez, Derrick

AU - Sanfilippo, Francesco

AU - Daniels, Benjamin

AU - Pearson, Sallie

AU - Martini, Angelita

AU - Preen, David

PY - 2017/10

Y1 - 2017/10

N2 - Aims: The field of pharmacoepidemiology research has grown significantly in recent decades in Australia and internationally. Despite recent investments in infrastructure and the development of policy frameworks to support research using routinely-collected data, there has been little matching investment in expanding Australia’s human capacity to do this research. Available literature suggests a need to broaden the skills base of the existing research workforce and to form larger, interdisciplinary teams incorporating capabilities ranging from computer science, research translation to research management. However, these needs are not based on empirical evidence or prioritised based on stakeholder needs. Therefore, research is needed to understand the state of the current Australian pharmacoepidemiology workforce and to prioritise its capacity building needs. This is important now in light of Australia’s growing infrastructure of routinely-collected datasets, including Pharmaceutical Benefits Scheme data. Therefore, we aim to: (1) enumerate the number of pharmacoepidemiology researchers available and estimate the number required in the Australian setting; (2) profile the current pharmacoepidemiology research workforce (e.g. skills, qualifications); and (3) explore views and perspectives of senior stakeholders and researchers on issues relevant to building capacity in the pharmacoepidemiology research workforce and research environment within the country. This paper presents our proposed study and research approach to a key target audience.Methods: Interviews with senior stakeholders (face-to-face or Skype) and surveys of pharmacoepidemiology researchers (using SurveyMonkey) will be undertaken in Australia to identify issues pertinent to building capacity in the pharmacoepidemiology research workforce. Mixed-methods approach will be used to analyse responses.Results and conclusion: This project addresses one of the aims of a major Australian Centre of Research Excellence: to build national workforce capacity and processes in pharmacoepidemiology research and policy translation. Findings from this study will allow the development of a National program to build workforce capacity in pharmacoepidemiology research.

AB - Aims: The field of pharmacoepidemiology research has grown significantly in recent decades in Australia and internationally. Despite recent investments in infrastructure and the development of policy frameworks to support research using routinely-collected data, there has been little matching investment in expanding Australia’s human capacity to do this research. Available literature suggests a need to broaden the skills base of the existing research workforce and to form larger, interdisciplinary teams incorporating capabilities ranging from computer science, research translation to research management. However, these needs are not based on empirical evidence or prioritised based on stakeholder needs. Therefore, research is needed to understand the state of the current Australian pharmacoepidemiology workforce and to prioritise its capacity building needs. This is important now in light of Australia’s growing infrastructure of routinely-collected datasets, including Pharmaceutical Benefits Scheme data. Therefore, we aim to: (1) enumerate the number of pharmacoepidemiology researchers available and estimate the number required in the Australian setting; (2) profile the current pharmacoepidemiology research workforce (e.g. skills, qualifications); and (3) explore views and perspectives of senior stakeholders and researchers on issues relevant to building capacity in the pharmacoepidemiology research workforce and research environment within the country. This paper presents our proposed study and research approach to a key target audience.Methods: Interviews with senior stakeholders (face-to-face or Skype) and surveys of pharmacoepidemiology researchers (using SurveyMonkey) will be undertaken in Australia to identify issues pertinent to building capacity in the pharmacoepidemiology research workforce. Mixed-methods approach will be used to analyse responses.Results and conclusion: This project addresses one of the aims of a major Australian Centre of Research Excellence: to build national workforce capacity and processes in pharmacoepidemiology research and policy translation. Findings from this study will allow the development of a National program to build workforce capacity in pharmacoepidemiology research.

KW - Workforce

KW - pharmacoepidemiology

UR - https://acpe2017.org/program/

UR - https://acpe2017.org/wp-content/uploads/2017/01/ISPE-ACPE10-Poster-program-101017.pdf

UR - https://acpe2017.org/wp-content/uploads/2017/01/ACPE-poster-abstracts-1.pdf

M3 - Conference presentation/ephemera

ER -

Lopez D, Sanfilippo F, Daniels B, Pearson S, Martini A, Preen D. Identifying barriers and priority areas for building workforce capacity in pharmacoepidemiology research in Australia. 2017. Paper presented at Asian Conference on Pharmacoepidemiology, Brisbane, Australia.